Ayala Pharmaceuticals Inc (ADXS)

[abuhafsa]

I was thinking the same thing last night, that this is most likely an end of year reprioritization decision at Amgen. Maybe the want to refocus on other types of immunotherapies and LM based is not one of them.

But I am surprised that such 'agreements' can be terminated so easily by one party without much financial consequence. After all, this decision could have been a one minute waving of the hand in an exec meeting but it's left ADXS in the lurch almost unable to survive. Does anyone have any idea what type of financial penalties Amgen owe ADXS as a result of this termination? Will it bring in sufficient cash to stay alive to fight another day?